Action AVTX AVALO THERAPEUTICS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Avalo Therapeutics, Inc.

Actions

AVTX

US05338F3064

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 27/06/2024 		Varia. 5j. Varia. 1 janv.
13,2 USD +1,23% Graphique intraday de Avalo Therapeutics, Inc. -0,45% +45,05%
24/06 Avalo Therapeutics nomme un directeur juridique MT
24/06 Avalo Therapeutics, Inc. nomme Paul Varki au poste de directeur juridique CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Avalo Therapeutics : 2024 Proxy Statement
Avalo Therapeutics Names Chief Legal Officer
Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer
Avalo Therapeutics, Inc. Appoints Paul Varki as Chief Legal Officer
Avalo Therapeutics : June 2024 Corporate Presentation
Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit
Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
North American Morning Briefing : Stock Futures -2-
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
Avalo Reports 2023 Financial Results and Provides Business Updates
Avalo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Avalo Reports 2023 Financial Results and Provides Business Updates
Sector Update: Health Care Stocks Rise Late Afternoon
Top Midday Gainers
Wall Street Set to Open Flat in Thursday Trading; Q4 US GDP Revised Up, Weekly Jobless Claims Fall
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Key Economic Data
US Futures Little Changed Pre-Bell Thursday Ahead of Raft of Economic Data
Top Premarket Gainers
Avalo Therapeutics, Inc. announced that it has received $115.6 million in funding from Deep Track Capital, LP, TCG Crossover Management, LLC, BVF Partners L.P., RA Capital Management, L.P., Commodore Capital LP, Petrichor Holdings, LLC
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action AVTX
  4. Actualités Avalo Therapeutics, Inc.
  5. Autres langues